BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection and Symptomatic Disease in Five-Month Follow-Up: A Retrospective Cohort Study

To combat the COVID-19 pandemic, a mass vaccination campaign was initiated in Italy on 27 December 2020. The vaccine available to immunize Italian healthcare workers (HCWs) was the BNT162b2 mRNA COVID-19 vaccine (Comirnaty). This study evaluated the effectiveness of the vaccine against documented SA...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianchi, Francesco Paolo, Tafuri, Silvio, Migliore, Giovanni, Vimercati, Luigi, Martinelli, Andrea, Lobifaro, Annamaria, Diella, Giusy, Stefanizzi, Pasquale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538139/
https://www.ncbi.nlm.nih.gov/pubmed/34696252
http://dx.doi.org/10.3390/vaccines9101143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538139/
https://www.ncbi.nlm.nih.gov/pubmed/34696252
http://dx.doi.org/10.3390/vaccines9101143

Ejemplares similares